MARAVAI LIFESCIENCES H

Maravai LifeSciences To Host Earnings Conference Call on Monday, May 10, 2021

13 Apr 2021 16:15:00 By Nasdaq GlobeNewswire

Maravai LifeSciences Announces Closing of Secondary Offering of Class A Common Stock by Selling Stockholders and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

12 Apr 2021 16:30:00 By Nasdaq GlobeNewswire

Maravai LifeSciences Announces Pricing of an Upsized Secondary Offering of Class A Common Stock by Selling Stockholders

07 Apr 2021 20:20:43 By Nasdaq GlobeNewswire

Maravai LifeSciences Announces Launch of Proposed Secondary Offering of Class A Common Stock by Selling Stockholders

05 Apr 2021 17:30:00 By Nasdaq GlobeNewswire

Maravai LifeSciences Announces Preliminary Unaudited First Quarter Revenues and Income From Operations Range

05 Apr 2021 16:05:00 By Nasdaq GlobeNewswire

Maravai LifeSciences Offers End-to-End mRNA Production with the Launch of TriLink BioTechnologies' Plasmid DNA Manufacturing Services

15 Mar 2021 08:05:00 By Nasdaq GlobeNewswire

Maravai LifeSciences Reports Fourth Quarter and Full Year 2020 Financial Results and Initiates 2021 Financial Guidance

02 Mar 2021 16:05:00 By Nasdaq GlobeNewswire

Maravai LifeSciences Announces March 2021 Investor Conference Schedule

01 Mar 2021 07:05:00 By Nasdaq GlobeNewswire

Maravai LifeSciences Expands Its Intellectual Property Portfolio

10 Feb 2021 07:05:00 By Nasdaq GlobeNewswire

Maravai LifeSciences To Host Earnings Conference Call on Tuesday, March 2, 2021

28 Jan 2021 16:15:01 By Nasdaq GlobeNewswire